These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33985809)

  • 1. Commentary: Angiotensin II: Expanding the rescue options for vasoplegia.
    Augoustides JG
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1417-1418. PubMed ID: 33985809
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
    Ortoleva J; Shapeton A; Vanneman M; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
    Carley M; Schaff J; Lai T; Poppers J
    A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Vasoplegic Shock During Coronary Artery Bypass Surgery: Therapeutic challenges and Dilemmas in Hemodynamic Rescue.
    Shah R; Wenger RK; Patel PA; Davis S; Ha B; Feinman JW; Patel S; Pulton D; Weiss SJ; Restrepo-Cardenas J; Aljure OD; Vasquez CR; Augoustides JG
    J Cardiothorac Vasc Anesth; 2020 May; 34(5):1341-1347. PubMed ID: 32146101
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
    Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
    Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
    Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
    Chatterjee S
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1415-1416. PubMed ID: 33888313
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
    Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene Blue for Vasoplegic Syndrome.
    Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
    Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery.
    Riha H; Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):736-8. PubMed ID: 21684764
    [No Abstract]   [Full Text] [Related]  

  • 12. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
    Papazisi O; Palmen M; Danser AHJ
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.
    Burnes ML; Boettcher BT; Woehlck HJ; Zundel MT; Iqbal Z; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):1012-1014. PubMed ID: 27838199
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue is associated with poor outcomes in vasoplegic shock.
    Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique case of purple urine: A case report and literature review.
    Aklilu AM; Avigan ZM; Brewster UC
    Clin Nephrol; 2021 May; 95(5):273-277. PubMed ID: 33605870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene Blue Does Not Improve Vasoplegia After Left Ventricular Assist Device Implantation.
    Saha A; Jennings DL; Ning Y; Kurlansky P; Miltiades AN; Spellman JL; Sanchez J; Yuzefpolskaya M; Colombo PC; Takayama H; Naka Y; Takeda K
    Ann Thorac Surg; 2021 Mar; 111(3):800-808. PubMed ID: 32758558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
    Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
    A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene Blue as an Adjunct to Treat Vasoplegia in Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass: A Literature Review.
    Arevalo VN; Bullerwell ML
    AANA J; 2018 Dec; 86(6):455-463. PubMed ID: 31584419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Con: methylene blue should not be used routinely for vasoplegia perioperatively.
    Andritsos MJ
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):739-43. PubMed ID: 21684763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.